The idea is spreading thanks to a new startup focused on providing support for cardiologists.

Earlier this year Congress extended CMS’s hospital-at-home waiver for five years via the Consolidated Appropriations Act of 2026. With that bold stroke, ‘HaH’ services became eligible for Medicare reimbursement through September of 2030. 

Federal regulators alleged that U.S. Anesthesia Partners—a portfolio company of Welsh, Carson, Anderson & Stowes—engaged in a “roll-up scheme” in Texas that effectively eliminated the competition. The company denies the allegations, but has agreed to undisclosed terms that would see the lawsuit resolved. 

The nonfiction book market is flooded with titles mentioning AI or artificial intelligence. Here’s a new work that will shake your world whether you’re an AI lover, loather or someone in between. 

Administrative AI can meaningfully cut providers’ price tags on prior authorization processes. Yet the technology is not doing much to reduce overall system-level costs. And it tends to increase billing intensity, inflating medical spending as it does so. 

Researchers found enrollment correlated with big reductions in medical debt as signaled by collections activity and subprime credit scores.

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

The wound and burn gels are manufactured by Integra LifeSciences. Defective packaging could cause the sterile barrier to fail, exposing the gels to pathogens. Due to the risk of severe infections, all recalled products must be removed from where they are used and sold.